This video was recorded April 16, 2024 at the 2nd Annual LiveLung Small Cell Summit The 2nd Annual LiveLung Small Cell Summit was held April 16-17, 2024 in Raleigh, NC. We were honored to bring together Small Cell Lung Cancer Patients and their caregivers with ten renowned experts in the field of SCLC, including Melissa Abel, MD.
About the Speaker
Melissa Abel, MD
Co-chief Fellow Hematology/Oncology, National Institutes of Health
Melissa Abel, MD, is a Clinical Research Fellow at the National Cancer Institute. She works as a junior investigator in the clinic and lab of Dr. Anish Thomas. She completed her medical training at Duke University where she participated in the Howard Hughes Medical Fellows program, studying CAR-T cell therapies for brain tumors. She attended UCLA for internal medicine residency before coming to the National Institutes of Health for her Oncology Fellowship, where she currently serves as a Chief Fellow. In addition to treating patients on lung and neuroendocrine cancer clinical trials, she researches the tumor microenvironment of SCLC and how it contributes to chemotherapy resistance.
The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical. The 2nd Annual LiveLung Small Cell Lung Cancer Summit was made possible in-part by grants from AstraZeneca, Amgen, Henlius, Jazz Pharmaceutical, Catalyst, and Gilead.
This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.
LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.